On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayNov 07, 2017 11:05 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Supplements Popular Beverage with Legal CBD

Unique patented drug delivery platform Active in world’s largest beverage market Technology that compliments rather than competes with CBD companies An old and popular beverage is being supplemented in a healthy, flavorful way now that Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is on the scene. Having increased its ownership stake in PoViva Tea, LLC from 51% to 100%, the innovative drug delivery biotech plans to apply its patented DehydraTECH™ technology to supplement a range of black teas with cannabidiol (CBD) from hemp. After water, tea is the most widely consumed beverage in the world and is an ideal adjuvant…

Continue Reading

MondayNov 06, 2017 2:14 pm

Skinvisible, Inc.’s (SKVI) Patented Polymer Delivery Technology Could Take CBD Products to the Next Level

Skinvisible already develops hemp-based products and is expanding its product line of cannabis-based topical product market Research verifies its Invisicare® technology improves the penetration rate and boosts the availability of the cannabis ingredients in both topical and transdermal products Skinvisible has entered a strategic partnership with Canopy Growth Corporation for the sale of its product formulations in the Canadian market Invisicare®, a proprietary topical drug delivery technology developed by Skinvisible, Inc. (OTCQB: SKVI), has a potentially wide range of applications in the cannabis market. The technology improves the delivery of pharmaceutical and medicinal compounds to and through the skin, which…

Continue Reading

MondayNov 06, 2017 11:20 am

PotNetwork Holding Inc. (POTN) Positioned for a Bright Future in the CBD Market

PotNetwork’s subsidiary, Diamond CBD, reports record sales of $1.76 million in August 2017 Acknowledged industry experts appointed to advisory board New line of CBD-infused honey products launched in October 2017 The hemp-derived cannabidiol (CBD) market is projected to show phenomenal growth over the next few years. The Hemp Business Journal has projected a compound annual growth rate (CAGR) of 53 percent for CBD products derived from hemp, estimating this market to be worth $1.8 billion by 2020 (http://cnw.fm/qf0A1). PotNetwork Holding, Inc. (OTC: POTN) is in a strong position to take advantage of this growth through its subsidiary, Diamond CBD, with…

Continue Reading

ThursdayNov 02, 2017 3:27 pm

AV1 Group, Inc. (AVOP) is “One to Watch”

Strategic approach to cannabis and hemp industry through networking architecture Legal marijuana markets estimated to reach $22.6 billion by 2021 Branded “hempSMART Brain™” CBD product is first to be offered by direct market Wellness industry is now $1.9 trillion per year with huge growth potential AV1 Group, Inc. (OTC: AVOP) is a publicly traded investment and holding company established to identify, secure and monetize emerging growth companies in a number of sectors that include cannabis related technologies, grow houses and cultivation, and e-commerce businesses positioned for exponential growth. After identifying businesses displaying revolutionary concepts able to develop a substantial footprint…

Continue Reading

ThursdayNov 02, 2017 2:21 pm

India Globalization Capital, Inc. (NYSE: IGC) Targets Multiple Health Concerns with Cannabis-based Therapies

6 patents filed for pain management, eating disorders and epilepsy Additional patents underway for PTSD, depression, Alzheimer’s and Parkinson’s disease Revenue potential of each cannabis-based therapy could fetch between $100 million to $500 million India Globalization Capital (NYSE AMERICAN: IGC) is a first mover in developing a portfolio of products using cannabis-based “combination therapies” for the treatment of Alzheimer’s, cachexia, pain, and other life-altering conditions. The company’s most recent research and development focus continues to be on readying a line of cannabis-based products targeting Alzheimer’s disease utilizing novel data (http://cnw.fm/1hUKu). This cannabis-based combination therapy shows promise for Alzheimer’s sufferers, says…

Continue Reading

WednesdayNov 01, 2017 1:05 pm

AppSwarm, Inc. (SWRM) Leverages Technology and Business Expertise to Enter the Cannabis Market Through SinglePoint, Inc. (SING) Joint Venture

SWRM has four diversified revenue streams as it seeks to grow in multi-platform games, offers its expertise to develop new cannabis apps under SinglePoint’s SingleSeed subsidiary brand SWRM managers project company FY2018 volume of $6 million-$7 million Cannabis market projected to reach $50 billion by 2025 AppSwarm, Inc. (OTC: SWRM) has four key revenue streams and is using its business and technical expertise to enter the cannabis mobile app market in partnership with SinglePoint, Inc. (OTC: SING). The two companies have announced a letter of agreement to roll-out cannabis industry mobile apps (http://cnw.fm/Vhx75). They said they would generate their first…

Continue Reading

Official NewsWire Relationships

Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo USA CBD Expo

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722